{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-25-007849","form_type":"8-K","ticker":"CELZ","cik":"0001187953","company_name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","filed_at":"2025-10-31T23:59:59+00:00","discovered_at":"2026-05-14T18:02:38.945314+00:00","generated_at":"2026-05-17T01:04:05.433564+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"CELZ raises ~$4.2M via warrant exercise inducement; issues 2.79M new warrants","bullets":["Holders of 1,116,136 warrants exercised at $3.75/share, yielding $4.2M gross proceeds.","Company issued 2,790,340 new inducement warrants at $3.75/share, exercisable 5 years after shareholder approval.","Roth Capital received 8% fee plus $40,000 expense reimbursement for acting as financial advisor.","Proceeds to be used for working capital and general corporate purposes.","Exercise price of certain 2021/2022 warrants reduced to $4.73 per share."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-25-007849","json":"https://secwatch.observer/filing/0001477932-25-007849.json","markdown":"https://secwatch.observer/filing/0001477932-25-007849.md","text":"https://secwatch.observer/filing/0001477932-25-007849.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1187953/000147793225007849/0001477932-25-007849-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1187953/000147793225007849/celz_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T01:04:05.433564+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"405e2ac63a3b1ac143be33b6c0047140cd653f18","claim":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. issued 2,790,340 shares of common stock of warrant to holders of existing warrants for cash exercise of existing warrants at $3.75 per share for aggregate gross proceeds of approximately $4.2 million.","evidence_excerpt":"On October 29, 2025, Creative Medical Technology Holdings, Inc. (the “Company”) entered into warrant exercise inducement offer letters (the “Inducement Letters”) with the holders (the “Holders”) of warrants to purchase an aggregate of 1,116,136 shares of the Company’s common stock originally issued on March 6, 2025 (collectively, the “Existing Warrants”), pursuant to which the Holders agreed to exercise the Existing Warrants at their current exercise price of $3.75 per share, in exchange for the Company’s agreement to issue the Holders new warrants to purchase an aggregate of 2,790,340 shares of common stock (the “Inducement Warrants”).","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1187953/000147793225007849/0001477932-25-007849-index.htm","confidence":0.92,"family_label":"Equity Issuances","details":[{"label":"Security","value":"warrant"},{"label":"Shares","value":"2,790,340 shares of common stock"},{"label":"Purchaser","value":"holders of existing warrants"},{"label":"Consideration","value":"cash exercise of existing warrants at $3.75 per share for aggregate gross proceeds of approximately $4.2 million"}],"fact_type":"equity_issuance"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}